Analysis of differentially expressed proteins in cancerous and normal colonic tissues

World Journal of Gastroenterology

Volumn 12, Issue 31, 2006, Pages 4973-4980

  Gam, Lay Ham ^a   Leow, Chiuan Herng ^a   Man, Che Nin ^b   Gooi, Boon Hui ^c   Singh, Manjit ^c  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b UNIVERSITY MALAYSIA PAHANG   (Malaysia)

^c HOSPITAL PULAU PINANG   (Malaysia)

Author keywords

Colon cancer; Proteomics; Sequential protein extraction; Tissue specimens

Indexed keywords

BUFFER; PROTEIN; TRYPSIN;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CANCER GROWTH; CASE REPORT; COLON CANCER; COMPUTER PROGRAM; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HUMAN; HUMAN TISSUE; HYDROPHOBICITY; IMAGE ANALYSIS; ION TRAP MASS SPECTROMETRY; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEOMICS;

EID: 33748297749     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i31.4973     Document Type: Article

References (51)

1. Fearon ER. Molecular biology of gastrointestinal cancers. In: De Vita VT Jr, Hellman S, Rosenberg SA. (eds). Cancer: principles and practice of oncology. 6th ed. Philadelphia: Lippincott, Williams, and Wilkins Press, 2001: 1037-1049
2. Harkins L, Volk AL, Samanta M, Mikolaenko I, Britt Wj, Bland KI, Cobbs CS. Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet 2002; 360: 1557-1563
3. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-767
4. Alaiya AA, Franzen B, Auer G, Linder S. Cancer proteomics: from identification of novel markers to creation of artifical learning models for tumor classification. Electrophoresis 2000; 21: 1210-1217
5. Stulik J, Hernychova L, Porkertova S, Knizek J, Macela A, Bures J, Jandik P, Langridge JI, Jungblut PR. Proteome study of colorectal carcinogenesis. Electrophoresis 2001; 22: 3019-3025
6. Chong BE, Hamler RL, Lubman DM, Ethier SP, Rosenspire AJ, Miller FR. Differential screening and mass mapping of proteins from premalignant and cancer cell lines using nonporous reversed-phase HPLC coupled with mass spectrometric analysis. Anal Chem 2001; 73: 1219-1227
7. Emmert-Buck MR, Gillespie JW, Paweletz CP, Ornstein DK, Basrur V, Appella E, Wang QH, Huang J, Hu N, Taylor P, Petricoin EF 3rd. An approach to proteomic analysis of human tumors. Mol Carcinog 2000; 27: 158-165
8. Molloy MP, Herbert BR, Walsh BJ, Tyler MI, Traini M, Sanchez JC, Hochstrasser DF, Williams KL, Gooley AA. Extraction of membrane proteins by differential solubilization for separation using two-dimensional gel electrophoresis. Electrophoresis 1998; 19: 837-844
9. Gam LH, Aishah L. Identification and confirmation of urinary human chorionic gonadotropin using in-gel digestion and HPLC/MS/MS analysis. Jurnal Biosains 2002; 13 (1): 27-34
10. Hjelmeland LM. Solubilization of native membrane proteins. Methods Enzymol 1990; 182: 253-264
11. Rabilloud T. Use of thiourea to increase the solubility of membrane proteins in two-dimensional electrophoresis. Electrophoresis 1998; 19: 758-760
12. Henzel WJ, Billeci TM, Stults JT, Wong SC, Grimley C, Watanabe C. Identifying proteins from two-dimensional gels by molecular mass searching of peptide fragments in protein sequence databases. Proc Natl Acad Sci USA 1993; 90: 5011-5015
13. Figeys D, Gygi SP, Zhang Y, Watts J, Gu M, Aebersold R. Electrophoresis combined with novel mass spectrometry techniques: powerful tools for the analysis of proteins and proteomes. Electrophoresis 1998; 19: 1811-1818
14. Duvet S, Op De Beeck A, Cocquerel L, Wychowski C, Cacan R, Dubuisson J. Glycosylation of the hepatitis C virus envelope protein E1 occurs posttranslationally in a mannosylphosphoryldolichol-deficient CHO mutant cell line. Glycobiology 2002; 12: 95-101
15. Fountoulakis M, Tsangaris G, Oh JE, Maris A, Lubec G. Protein profile of the HeLa cell line. J Chromatogr A 2004; 1038: 247-265
16. Williams K, Chubb C, Huberman E, Giometti CS. Analysis of differential protein expression in normal and neoplastic human breast epithelial cell lines. Electrophoresis 1998; 19: 333-343
17. Leong ASY, Cooper K, Leong FJM. Manual of diagnostic antibodies for immunohistology. London: Greenwich Medical Media Pub, 1999: 25-35
18. Hembrough TA, Kralovich KR, Li L, Gonias SL. Cytokeratin 8 released by breast carcinoma cells in vitro binds plasminogen and tissue-type plasminogen activator and promotes plasminogen activation. Biochem J 1996; 317 (Pt 3): 763-769
19. Ludowyke RI, Warton K, Scurr LL. Inhibition of antigen and calcium ionophore induced secretion from RBL-2H3 cells by phosphatase inhibitors. Cell Biol Int 1998; 22: 855-865
20. Birchmeier C, Birchmeier W, Brand-Saberi B. Epithelial-mesenchymal transitions in cancer progression. Acta Anat (Basel) 1996; 156: 217-226
21. Seshadri R, Raymond WA, Leong AS, Horsfall DJ, McCaul K. Vimentin expression is not associated with poor prognosis in breast cancer. Int J Cancer 1996; 67: 353-356
22. Solomon A, Murphy CL, Weaver K, Weiss DT, Hrncic R, Eulitz M, Donnell RL, Sletten K, Westermark G, Westermark P. Calcifying epithelial odontogenic (Pindborg) tumor-associated amyloid consists of a novel human protein. J Lab Clin Med 2003; 142: 348-355
23. Afjehi-Sadat L, Shin JH, Felizardo M, Lee K, Slavc I, Lubec G. Detection of hypothetical proteins in 10 individual human tumor cell lines. Biochim Biophys Acta 2005; 1747: 67-80
24. Simpson-Haidaris PJ, Rybarczyk B. Tumors and fibrinogen. The role of fibrinogen as an extracellular matrix protein. Ann N Y Acad Sci 2001; 936: 406-425
25. Edwards RL, Rickles FR, Moritz TE, Henderson WG, Zacharski LR, Forman WB, Cornell CJ, Forcier RJ, O'Donnell JF, Headley E. Abnormalities of blood coagulation tests in patients with cancer. Am J Clin Pathol 1987; 88: 596-602
26. Ogura T, Hirao F, Tsubura E, Yamamura Y. Autoradiographic study on localization of fibrinogen in rabbit lung cancer. Gann 1971; 62: 367-372
27. Wojtukiewicz MZ, Zacharski LR, Memoli VA, Kisiel W, Kudryk BJ, Rousseau SM, Stump DC. Abnormal regulation of coagulation/fibrinolysis in small cell carcinoma of the lung. Cancer 1990; 65: 481-485
28. Cardinali M, Uchino R, Chung SI. Interaction of fibrinogen with murine melanoma cells: covalent association with cell membranes and protection against recognition by lymphokine-activated killer cells. Cancer Res 1990; 50: 8010-8016
29. Atagi S, Sone S, Fukuta K, Ogura T. Inhibition by fibrin coagulation of lung cancer cell destruction by human interleukin-2-activated killer cells. Jpn J Cancer Res 1992; 83: 1088-1094
30. Nagy JA, Masse EM, Herzberg KT, Meyers MS, Yeo KT, Yeo TK, Sioussat TM, Dvorak HF. Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation. Cancer Res 1995; 55: 360-368
31. Yamaguchi T, Kimura H, Yokota S, Yamamoto Y, Hashimoto T, Nakagawa M, Ito M, Ogura T. Effect of IL-6 elevation in malignant pleural effusion on hyperfibrinogenemia in lung cancer patients. Jpn J Clin Oncol 2000; 30: 53-58
32. Maguire PB, Moran N, Cagney G, Fitzgerald DJ. Application of proteomics to the study of platelet regulatory mechanisms. Trends Cardiovasc Med 2004; 14: 207-220
33. Broude NE, Modyanov NN, Monastyrskaya GS, Sverdlov ED. Advances in Na+,K+-ATPase studies: from protein to gene and back to protein. FEBS Lett 1989; 257: 1-9
34. Whittington DA, Waheed A, Ulmasov B, Shah GN, Grubb JH, Sly WS, Christianson DW. Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells. Proc Natl Acad Sci USA 2001; 98: 9545-9550
35. Tureci O, Sahin U, Vollmar E, Siemer S, Gottert E, Seitz G, Parkkila AK, Shah GN, Grubb JH, Pfreundschuh M, Sly WS. Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers. Proc Natl Acad Sci USA 1998; 95: 7608-7613
36. Cuatico W, Cho JR, Spiegelman S. Particles with RNA of high molecular weight and RNA-directed DNA polymerase in human brain tumors. Proc Natl Acad Sci USA 1973; 70: 2789-2793
37. Fu H, Subramanian RR, Masters SC. 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol 2000; 40: 617-647
38. Ichimura T, Isobe T, Okuyama T, Takahashi N, Araki K, Kuwano R, Takahashi Y. Molecular cloning of cDNA coding for brain-specific 14-3-3 protein, a protein kinase-dependent activator of tyrosine and tryptophan hydroxylases. Proc Natl Acad Sci USA 1988; 85: 7084-7088
39. Masters SC, Subramanian RR, Truong A, Yang H, Fujii K, Zhang H, Fu H. Survival-promoting functions of 14-3-3 proteins. Biochem Soc Trans 2002; 30: 360-365
40. Friedman DB, Hill S, Keller JW, Merchant NB, Levy SE, Coffey RJ, Caprioli RM. Proteome analysis of human colon cancer by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics 2004; 4: 793-811
41. Yang P, Cunningham JM, Halling KC, Lesnick TG, Burgart LJ, Wiegert EM, Christensen ER, Lindor NM, Katzmann JA, Thibodeau SN. Higher risk of mismatch repair-deficient colorectal cancer in alpha(1)-antitrypsin deficiency carriers and cigarette smokers. Mol Genet Metab 2000; 71: 639-645
42. Rosenberg S, Barr PJ, Najarian RC, Hallewell RA. Synthesis in yeast of a functional oxidation-resistant mutant of human alpha-antitrypsin. Nature 1984; 312: 77-80
43. Harris CC, Cohen MH, Connor R, Primack A, Saccomanno G, Talamo RC. Serum alpha1-antitrypsin in patients with lung cancer or abnormal sputum cytology. Cancer 1976; 38: 1655-1657
44. Govorukhina NI, Keizer-Gunnink A, van der Zee AG, de Jong S, de Bruijn HW, Bischoff R. Sample preparation of human serum for the analysis of tumor markers. Comparison of different approaches for albumin and gamma-globulin depletion. J Chromatogr A 2003; 1009: 171-178
45. Bloom GS, Endow SA. Motor proteins 1: kinesins. Protein Profile 1995; 2: 1105-1171
46. Venkatesh LK, Gettemeier T, Chinnadurai G. A nuclear kinesin-like protein interacts with and stimulates the activity of the leucine-rich nuclear export signal of the human immunodeficiency virus type 1 rev protein. J Virol 2003; 77: 7236-7243
47. Scanlan MJ, Gout I, Gordon CM, Williamson B, Stockert E, Gure AO, Jager D, Chen YT, Mackay A, O'Hare MJ, Old LJ. Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression. Cancer Immunity 2001; 1: 4-21
48. Fontijn RD, Goud B, Echard A, Jollivet F, van Marle J, Pannekoek H, Horrevoets AJ. The human kinesin-like protein RB6K is under tight cell cycle control and is essential for cytokinesis. Mol Cell Biol 2001; 21: 2944-2955
49. Kabsch W, Vandekerckhove J. Structure and function of actin. Annu Rev Biophys Biomol Struct 1992; 21: 49-76
50. Vadlamudi RK, Shin J. Genomic structure and promoter analysis of the p62 gene encoding a non-proteasomal multiubiquitin chain binding protein. FEBS Lett 1998; 435: 138-142
51. Chou CC, Davis RC, Fuller ML, Slovin JP, Wong A, Wright J, Kania S, Shaked R, Gatti RA, Salser WA. Gamma-actin: unusual mRNA 3′-untranslated sequence conservation and amino acid substitutions that may be cancer related. Proc Natl Acad Sci USA 1987; 84: 2575-2579